SecBot SecBot

UTMD

UTAH MEDICAL PRODUCTS INC
Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. UT· CIK 0000706698 Healthcare & Medical Devices
$72.36 +0.39 (+0.54%)
Nov 16 4:00 PM ET · prev $71.97
Market cap
$234.4M
Micro cap
1 year
+31.7%
from $54.93 · Nov 17
30 days
−2.9%
from $74.55
52-week range
$53.80–76.66
−6% from high · low Nov 20
Avg volume 20D
33.4K
shares / day
Short interest
151.3K
≈4.8% of shares · +7.9%
Days to cover
3.9
at average volume
Insider net
+$66.8K
1 buyer · 0 sellers · 12 mo
New fund stakes
0
Q3 2026 13F · 0 exits
Filing reports
11
analyzed by SecBot
SecBot read MIXED 9 reports · 90 days
Balance 0 bearish · 1 bullish · 3 mixed · 5 neutral oldest → newest, height = score
Avg score ·High conf. 8/9

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBULLISH

    1 insider bought $66.8K at an average $66.75. No open-market sales. Price is 8% above their cost.

  • InstitutionsMIXED

    Q3 2026: 8 added (0 new), 10 trimmed or exited.

  • Short sellersSTEADY

    Short interest +7.9% to 151.3K shares. 3.9 days to cover, ≈4.8% of shares.

  • TrendDOWNTREND

    1% below its 50-day average.

Who's buying

13F· Q3 2026
0
new positions
0
exits
FundMoveSharesValue
GEODE CAPITAL MANAGEMENT, LLCTRIM76,377$5.7M
Bank of New York Mellon CorpADD47,301$3.5M
MORGAN STANLEYTRIM45,834$3.4M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPDOUBLED24,776$1.8M
Empowered Funds, LLCDOUBLED6,769$501.2K
UBS Group AGNEAR_EXIT2,187$161.9K
BARCLAYS PLCADD1,300$96.3K
BNP PARIBAS FINANCIAL MARKETSTRIM678$50.2K

Quarterly 13F filings are due 45 days after each quarter ends.

Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

Insider ledger

Form 4
$66.8K
bought · 1 insider
$0
sold · 0 insiders
+8.4%
vs their $66.75 cost
DateInsiderTypeValue
Oct 29, 2026
CORNWELL KEVIN L
Chairman, CEO
Oct 29, 2026
BUY$66.8K
Jun 29, 2026
RICHINS PAUL O
Director
Jun 29, 2026
GIFT$11.0K
May 28, 2026
Koopman Brian
Principal Financial Officer
May 28, 2026
GIFT$3.3K

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current QNoneNoneNo data$0.00
Next QNoneNoneNo data$0.00
Current FYNoneNoneNo data$0.00
Next FYNoneNoneNo data$0.00

Short side

FINRA· Oct 30, 2026
151,293
shares short
+7.9%
vs prior settlement
3.9
days to cover
≈4.8%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 3, 2026 SEC
Utah Medical Products announced a 1.6% increase in its regular quarterly cash dividend to $0.315 per share, payable…
8-K · Impact 2/10
Oct 29, 2026 SEC
UTMD Chairman and CEO Kevin Cornwell made an open-market purchase of 1,000 shares for $67K, his first buy in the last…
INSIDER-BUY · Impact 3/10
Oct 29, 2026 SEC
Utah Medical Products completed its issuer tender offer, purchasing 327,740 shares at $75.00 per share for a total of…
SC TO-I/A · Impact 4/10
Oct 29, 2026 Insider
CORNWELL KEVIN L bought 1,000 shares
Chairman, CEO @ $66.75 ($66.8K)
Oct 27, 2026 Earnings calendar
UTMD Q3 2026 Earnings Scheduled · 2026-10-27
Sep 30, 2026 Inst.
GEODE CAPITAL MANAGEMENT, LLC · TRIM
76,377 shares ($5.7M)
Sep 30, 2026 Inst.
Bank of New York · ADD
47,301 shares ($3.5M)
Jun 29, 2026 Insider
RICHINS PAUL O gifted 150 shares
Director @ $73.07 ($11.0K)

SecBot reports

11 filings · 1 bullish · 2 bearish · 3 mixed · 5 neutral
All UTMD filing & press-release reports (11)